2026 HIV Treatment and Prevention Agents Vaccines 
Pharmacy Times
AUGUST 2, 2025
These technologies prevent the risk of both hypo- and hyperglycemic episodes, facilitating safer fasting. The guidance is updated every 5 years, with the most recent update published in May 2025. Monitoring technology is valuable to assess glycemic control and enable timely interventions in T1D patients.
pharmaphorum
JUNE 29, 2022
COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The initial pandemic lockdowns prevented many patients from seeing doctors face-to-face.
Expert insights. Personalized for you.
Let's personalize your content